Table 1.
Characteristics of the entire study cohort (N = 7337)
| Sarcoidosis patients (n = 37, 0.5%) | Non-sarcoidosis patients (n = 7300, 99.5%) | p value | |
|---|---|---|---|
| Demographics | |||
| Age, median (IQR), year | 55.0 (50.0–65.0) | 62.0 (48.0–74.0) | 0.038 |
| Male, N (%) | 16 (43.2) | 4054 (55.5) | 0.139 |
| African American, N (%) | 24 (64.9) | 1891 (25.9) | < 0.001 |
| Caucassians, N (%) | 4 (10.8) | 1720 (23.6) | 0.367 |
| Comorbidities | |||
| CAD, N (%) | 4 (10.8) | 1205 (16.5) | 0.504 |
| CHF, N (%) | 7 (18.9) | 778 (10.7) | 0.109 |
| DM, N (%) | 14 (37.8) | 2739 (37.5) | 1.000 |
| HTN, N (%) | 20 (54.1) | 4080 (55.9) | 0.869 |
| CKD, N (%) | 5 (13.5) | 1073 (14.7) | 1.000 |
| COPD, N (%) | 8 (21.6) | 518 (7.1) | 0.004 |
| Asthma, N (%) | 7 (18.9) | 934 (12.8) | 0.318 |
| Obesity, N (%) | 20 (54.1) | 1973 (27.0) | < 0.001 |
| BMI, median (IQR) | 30.6 (25.4–35.6) | 27.4 (23.8–32.3) | 0.017 |
| Cancer, N(%) | 5 (13.5) | 895 (12.3) | 0.800 |
| Smoking, N (%) | 16 (43.2) | 1485 (20.3) | 0.002 |
| Outcomes | |||
| Admitted, N (%) | 22 (59.5) | 5002 (68.5) | 0.286 |
| Mortality, N(%) | 6 (16.2) | 1502 (20.6) | 0.683 |
| Intubation and MV, N (%) | 9 (24.3) | 1150 (15.8) | 0.172 |
| Mortality/intubation and MV, N (%) | 12 (32.4) | 1816 (24.9) | 0.339 |
HTN hypertension, CAD coronary artery disease, DM diabetes mellitus, CHF congestive heart failure, CKD chronic kidney disease, COPD chronic obstructive pulmonary disease, BMI body mass index